While it is possible that prostate cancer cells drive IRP2 overexpression by altering post-transcriptional regulation, our findings demonstrate that IRP2 is transcriptionally upregulated in prostate cancer cells (Figure 1). The gene discussed is IREB2; the disease is prostate carcinoma.